Long-Term Safety and Efficacy of Percutaneous Left Atrial Appendage Closure with the LAmbre Device

Table 3

Clinical outcomes during follow-up.

	n = 56
Follow-up time (months)	37.8 ± 23.5
Death	4 (7.1)
Noncardiac death	3 (5.4)
Cardiac death	1 (1.8)
Ischemic stroke	2 (3.6)
Hemorrhagic stroke	0
Device thrombosis	2 (3.6)
Systemic thromboembolism	0
LAA sealing by TEE examination
Residual flow <1 mm	2 (3.6)
Residual flow 1–3 mm	1 (1.8)
Residual flow >3 mm	0

LAA = left atrial appendage; TEE = transesophageal ultrasound.